Molecular Determinants Of Susceptibility And Progression In Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$6,006,551.00
Summary
Breast cancer is heterogeneous, making management a challenge. High-grade cancers including the ‘basal’ type are aggressive, often found in young women and have a propensity for distant spread. They are also associated with a BRCA1 gene mutation. We will study mechanisms that predispose some women to develop breast cancer, the process that allows cancers to grow at distant sites such as the brain and lungs, and how DNA repair proteins are implicated. This will allow development of new diagnostic ....Breast cancer is heterogeneous, making management a challenge. High-grade cancers including the ‘basal’ type are aggressive, often found in young women and have a propensity for distant spread. They are also associated with a BRCA1 gene mutation. We will study mechanisms that predispose some women to develop breast cancer, the process that allows cancers to grow at distant sites such as the brain and lungs, and how DNA repair proteins are implicated. This will allow development of new diagnostic tools and treatments.Read moreRead less
From Discovery To Innovation In Stuttering Treatment
Funder
National Health and Medical Research Council
Funding Amount
$5,124,148.00
Summary
Stuttering starts in 2-3-year olds and if not controlled causes a lifetime of social anxiety, and hinders educational and vocational achievement. Recent discoveries by the current team and colleagues have shown the disorder to be far more prevalent, and more of a public health problem, than previously thought. The team has developed efficacious treatments for stuttering children and adults. However, no country can afford the health care needed for all who stutter. The present research is designe ....Stuttering starts in 2-3-year olds and if not controlled causes a lifetime of social anxiety, and hinders educational and vocational achievement. Recent discoveries by the current team and colleagues have shown the disorder to be far more prevalent, and more of a public health problem, than previously thought. The team has developed efficacious treatments for stuttering children and adults. However, no country can afford the health care needed for all who stutter. The present research is designed to solve this problem by developing standalone Internet based stuttering treatments. These will be evaluated in a stepped care treatment approach for people who stutter, in Australia and internationally.Read moreRead less
Translating Molecular Determinants Of Susceptibility And Progression In Breast Cancer
Funder
National Health and Medical Research Council
Funding Amount
$6,510,085.00
Summary
Breast cancer is the most common cancer in women. Despite improvements in prevention, detection and treatment, it is the 2nd most common cause of cancer death in Australian women. Research advances in the last decade have improved our understanding of the pathways from susceptibility to progression and metastasis but this has mostly not yet translated into better outcomes. This program aims to translate some of our fundamental discoveries to improve outcome for affected women and their families.
This proposal is for a team of researchers and clinicians to explore the molecular control of the lymphatic vasculature. This network of lymphatic vessels, located in organs throughout the body, is critical for regulation of tissue fluid and immune function. It will identify new molecular pathways controlling lymphatic vessels and their interactions with other cells in the body and identify new diagnostic approaches and molecular targets for medicines to treat human diseases including cancer.
Development And Evaluation Of An Internet-based Clinic For Stuttering.
Funder
National Health and Medical Research Council
Funding Amount
$6,200,965.00
Summary
Stuttering is a prevalent disorder of speech production. The program of research will establish the world’s first Internet-based stuttering clinic to service all the clinical needs of child, adolescent and adult patients. The Internet-based clinic model will provide economical, scalable and translatable stuttering treatments that will, for the first time, provide a means to adequately manage the public health problem of stuttering.
Musculoskeletal Pain And Disability: Improving Outcomes Through Conservative Interventions
Funder
National Health and Medical Research Council
Funding Amount
$8,549,204.00
Summary
Musculoskeletal conditions (particularly back pain and osteoarthritis) are highly prevalent and have a major impact on health and well being of Australians. This Program aims to resolve the major priorities in the field: optimal methods to target the right treatment to the right person at the right time through our unique strategy to understand mechanisms and identify patient subgroups, and establish optimal methods to overcome barriers to translation of research to policy and practice.
Improved Outcomes For Children With Cancer Through Improved Target Identification And Drug Discovery: Neuroblastoma As A Model
Funder
National Health and Medical Research Council
Funding Amount
$6,394,247.00
Summary
The majority of children with neuroblastoma still die of their disease, and survivors have serious side-effects of cancer treatment. We aim to discover better therapies for children with this cancer, conducting clinical trials using existing and new drugs in novel combinations. We will also investigate novel ways of targeting neuroblastoma cells, and study possible prevention strategies for this and other embryonal cancers. This work will have application in other childhood and adult cancers.
Central to improving the management of patients with cancer is an understanding of the molecular drivers of cancer. Based on our fundamental discoveries about the role of cell growth and perturbed cell signalling as drivers of cancer we will use the integration of molecular and imaging biomarkers with targeted therapies to translate this knowledge into better outcomes for cancer patients with defined molecular drivers of their cancer.